GILEAD SCIENCES, INC. Total Liabilities & Equity 2008-2026 | GILD
What is total liabilities & equity?
Total liabilities and stockholders' equity equals total assets, reflecting the fundamental accounting equation.
What is GILEAD SCIENCES, INC.'s current total liabilities & equity?
GILEAD SCIENCES, INC. (GILD) annual total liabilities & equity for 2025 was $59.02B, a 0.05% increase from 2024. GILEAD SCIENCES, INC. total liabilities & equity for the quarter ending March 31, 2026 was $56.28B.
What was GILEAD SCIENCES, INC.'s total liabilities & equity in 2024?
GILEAD SCIENCES, INC. annual total liabilities & equity for 2024 was $58.99B, a 5.04% decline from 2023.
What was GILEAD SCIENCES, INC.'s total liabilities & equity in 2023?
GILEAD SCIENCES, INC. annual total liabilities & equity for 2023 was $62.13B, a 1.66% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year total liabilities & equity CAGR?
GILEAD SCIENCES, INC. total liabilities & equity grew at a compound annual growth rate (CAGR) of 2.91% from FY2020 to FY2025, going from $68.41B to $59.02B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $59.02B | +0.0% | 10-K |
| FY2024 | $58.99B | -5.0% | 10-K |
| FY2023 | $62.13B | -1.7% | 10-K |
| FY2022 | $63.17B | -7.0% | 10-K |
| FY2021 | $67.95B | -0.7% | 10-K |
| FY2020 | $68.41B | +11.0% | 10-K |
| FY2019 | $61.63B | -3.2% | 10-K |
| FY2018 | $63.67B | -9.4% | 10-K |
| FY2017 | $70.28B | +23.4% | 10-K |
| FY2016 | $56.98B | +10.2% | 10-K |
| FY2015 | $51.72B | +49.2% | 10-K |
| FY2014 | $34.66B | +53.5% | 10-K |
| FY2013 | $22.58B | +6.3% | 10-K |
| FY2012 | $21.24B | +22.8% | 10-K |
| FY2011 | $17.30B | +49.3% | 10-K |
| FY2010 | $11.59B | +19.5% | 10-K |
| FY2009 | $9.70B | +39.8% | 10-K |
| FY2008 | $6.94B | - | 10-K |